Premium
A RETROSPECTIVE ANALYSIS OF REAL‐WORLD OUTCOMES OF CHINESE ELDER PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)
Author(s) -
Liu P.,
Han Y.,
Jiang S.,
He X.,
Qin Y.,
Gui L.,
Zhou S.,
Zhou L.,
Yang J.,
Yang S.,
Wen T.,
Shi Y.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.85_2631
Subject(s) - medicine , rituximab , diffuse large b cell lymphoma , vincristine , regimen , progression free survival , population , surgery , clinical endpoint , prednisolone , etoposide , chemotherapy regimen , cyclophosphamide , lymphoma , oncology , chemotherapy , clinical trial , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom